Page last updated: 2024-09-03

pentosidine and Glycogen Storage Disease Type I

pentosidine has been researched along with Glycogen Storage Disease Type I in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baynes, JW; den Hollander, NC; Graaff, R; Mulder, DJ; Smit, AJ; Smit, GP; Thorpe, SR	1

Other Studies

1 other study(ies) available for pentosidine and Glycogen Storage Disease Type I

Article	Year
Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia. Journal of inherited metabolic disease, 2007, Volume: 30, Issue:6 Topics: Adolescent; Adult; Arginine; Atherosclerosis; Carotid Arteries; Collagen; Female; Glycation End Products, Advanced; Glycogen Storage Disease Type I; Humans; Lysine; Male; Oxidative Stress; Risk; Skin; Tunica Intima; Tunica Media	2007

Article

Year

Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia.

Journal of inherited metabolic disease, 2007, Volume: 30, Issue:6

Topics: Adolescent; Adult; Arginine; Atherosclerosis; Carotid Arteries; Collagen; Female; Glycation End Products, Advanced; Glycogen Storage Disease Type I; Humans; Lysine; Male; Oxidative Stress; Risk; Skin; Tunica Intima; Tunica Media

2007